Minaris Regenerative Medicine
Clara Alexandra Murillo has extensive experience in Quality Assurance within the pharmaceutical industry, currently serving as Quality Assurance Manager at Minaris Regenerative Medicine since January 2021. Prior roles include Supplier Quality Control Technician, Quality Assurance Documentation Senior Specialist, and Quality Assurance Supervisor at CorePharma LLC, where responsibilities encompassed maintaining compliance with GMP standards, supervising QA inspectors, and managing quality documentation processes. Additionally, Clara held the position of QA Documentation Supervisor at AKORN and contributed to quality control at Schering-Plough Corporation in various capacities, including as a Supplier Quality Control Inspector. Academic credentials include two MBA degrees in Management from Centenary University and Fairleigh Dickinson University, as well as a Bachelor of Arts in Political Science and International Comparative Studies from Kean University.
This person is not in any offices
Minaris Regenerative Medicine
Minaris Regenerative Medicine is a global contract development and manufacturing organization for the production of cell and gene therapy products. We offer our clients clinical and commercial manufacturing services, development solutions, and technologies. With more than 20 years’ experience in the field of regenerative medicine, we are trusted partner ensuring scalability, delivering high quality results, and achieving cost effective manufacturing. Our state-of-the-art facilities in the United States, Europe, and Asia, as well as our committed employees, enable us to supply patients worldwide with lifechanging therapies. At Minaris, we are creating cell therapy miracles together. Minaris Regenerative Medicine is wholly owned by the Resonac Group.